BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Jun 23, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-06-22

Reporting Person: Mueller Brian (SVP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-22	Common Stock	M	2671	$21.51	Acquired	15556	Direct
2017-06-22	Common Stock	S	2671	$100.00	Disposed	12885	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-22	Stock Option (Right to buy Common Stock)	$21.51	M	2671	Disposed	2020-05-11	Common Stock (2671)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.

F2: All shares sold at the same price.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.